CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in VANI — Vivani Medical, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in VANI

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$30,016

-$6,903 QoQ

Shares Held

30,016

0.0% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,185,699,337 across 288 Biotechnology names. VANI ranks #288 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,920,871	$857,745,736
2	REGN	Regeneron Pharmaceuticals, Inc.	804,508	$621,595,061
3	MRNA	Moderna, Inc.	4,734,356	$240,505,284
4	ALNY	Alnylam Pharmaceuticals, Inc.	673,356	$222,793,299
5	INSM	INSMED Inc	1,069,390	$174,866,652
6	RVMD	Revolution Medicines, Inc.	1,735,476	$168,775,041
7	INCY	Incyte Corp	1,729,102	$162,743,080
8	BBIO	BridgeBio Pharma, Inc.	1,976,094	$146,744,740

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$30,016	30,016	0.0%	Shares	Sole	2026-05-15
2025-12-31	$36,919	30,016	0.0%	Shares	Sole	2026-02-13
2025-09-30	$42,322	30,016	0.0%	Shares	Sole	2025-11-10
2025-06-30	$38,720	30,016	0.0%	Shares	Sole	2025-08-12
2025-03-31	$31,516	30,016	0.0%	Shares	Sole	2025-09-15
2024-12-31	$34,818	30,016	0.0%	Shares	Sole	2025-02-06
2024-09-30	$35,118	30,016	-0.0%	Shares	Sole	2024-11-12
2024-06-30	$37,821	30,017	0.0%	Shares	Sole	2024-08-12
2024-03-31	$55,531	30,017	0.0%	Shares	Sole	2024-05-09
2023-12-31	$30,617	30,017	0.0%	Shares	Sole	2024-02-06
2023-09-30	$30,617	30,017	0.0%	Shares	Sole	2023-11-08
2023-06-30	$36,320	30,017	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.